Five essential reads on South Africa today
Available with a BusinessLIVE Premium subscription for just R4 a day, these five insightful articles have been written by top writers from Business Day and Financial Mail
The Financial Mail's cover artwork is always original and provocative, and this week's is no exception. And the cover story - From industry darling to villain? FM goes inside Aspen's competition battle - is always proof that high-quality reportage is alive and well. It is available to Premium subscribers. This week, the story deals with the trials and tribulations of Aspen, SA's leading drug manufacturer. Until recently it was the darling of the markets, but a fistful of lawsuits has cast it in a new light. This from the story by journalist Giulietta Talevi (you might recognise Giulietta from Business Day TV): Stephen Saad’s frustration at Aspen being branded a "price gouger" that drove up the cost of life-saving medicine for profit is palpable. In an interview with the Financial Mail, the 53-year-old says Aspen Pharmacare has been the victim of a "perfect storm" that has led to his company being unfairly cast as a villain. "That was probably the most disappointing part: you’ve got ...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.